Comprehensive in vitro antiviral screening against viruses of pandemic potential under antiviral program for pandemics (APP) to support HIT-to-lead studies
Ended Awarded Last action
- Contract number
- 75N93023F00003
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $571,967
Award facts
- Contract value 94% obligated
-
- $571,967.00 Current, with exercised options
- $610,217.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $8,967 | |
| Original award | $563,000 |
About this award
Utah State University will provide comprehensive in vitro antiviral screening against viruses of pandemic potential under the Antiviral Program for Pandemics (APP) to support hit-to-lead studies. This $610,217 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases on September 5, 2023, to be completed by September 4, 2024. It is issued against the university's existing In Vitro Assessments of Antimicrobial Activity indefinite delivery contract, which supports the agency's screening and research efforts to develop treatments for emerging infectious diseases. No set aside designation was specified for this award.
Quick answers
Who was awarded contract 75N93023F00003?
75N93023F00003 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 5, 2023.
How much is contract 75N93023F00003 worth?
The government has obligated $571,967 on 75N93023F00003. Its potential value, with all options, is $610,217.
Is contract 75N93023F00003 an order under another contract?
Yes. 75N93023F00003 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93023F00003 competed?
The extent of competition for 75N93023F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award